NTRA - Natera, Inc.
NASDAQ
->
Healthcare
->
Diagnostics & Research
San Carlos,
United States
Type: Equity
NTRA price evolution
NTRA
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $642.1 | $668.71 | $381.11 | $403.15 |
| Short term investments | $236.88 | $267.85 | $354.83 | $408.86 |
| Net receivables | $278.29 | $255.15 | $260.06 | $246.78 |
| Inventory | $40.76 | $42.08 | $42.69 | $40.68 |
| Total current assets | $1258.55 | $1267.28 | $1065.51 | $1129.47 |
| Long term investments | ||||
| Property, plant & equipment | $167.75 | $163.04 | $164.86 | $170.12 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $183.15 | $179.24 | $182.38 | $189.41 |
| Total investments | $236.88 | $267.85 | $354.83 | $408.86 |
| Total assets | $1441.7 | $1446.52 | $1247.89 | $1318.88 |
| Current liabilities | ||||
| Accounts payable | $15 | $21.32 | $21.11 | $36.12 |
| Deferred revenue | $35.74 | $36.05 | $37.15 | $38.09 |
| Short long term debt | $80.4 | $80.44 | $80.42 | $80.4 |
| Total current liabilities | $307.27 | $289.92 | $276.86 | $290.97 |
| Long term debt | $349.97 | $350.91 | $353.39 | $355.83 |
| Total noncurrent liabilities | $369.1 | $371.94 | $374.89 | $377.34 |
| Total debt | $430.37 | $431.34 | $433.81 | $436.23 |
| Total liabilities | $676.37 | $661.86 | $651.75 | $668.31 |
| Shareholders' equity | ||||
| Retained earnings | -$2377.44 | -$2299.41 | -$2190.38 | -$2079.57 |
| Other shareholder equity | -$3.08 | -$5.4 | -$9.2 | -$11.8 |
| Total shareholder equity | $765.33 | $784.66 | $596.15 | $650.57 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $642.1 | $466.09 | $84.61 | $48.85 |
| Short term investments | $236.88 | $432.3 | $829.9 | $688.61 |
| Net receivables | $278.29 | $244.38 | $122.07 | $78.56 |
| Inventory | $40.76 | $35.41 | $26.91 | $20.03 |
| Total current assets | $1258.55 | $1211.82 | $1093.14 | $862.66 |
| Long term investments | ||||
| Property, plant & equipment | $167.75 | $164.33 | $124.53 | $54.75 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $183.15 | $182.66 | $143.35 | $69.49 |
| Total investments | $236.88 | $432.3 | $829.9 | $688.61 |
| Total assets | $1441.7 | $1394.47 | $1236.49 | $932.15 |
| Current liabilities | ||||
| Accounts payable | $15 | $31.15 | $27.21 | $8.1 |
| Deferred revenue | $35.74 | $30.78 | $28.72 | $72.93 |
| Short long term debt | $80.4 | $80.35 | $50.05 | $50.05 |
| Total current liabilities | $307.27 | $310.5 | $218.96 | $199.05 |
| Long term debt | $349.97 | $281.65 | $341.43 | $223.74 |
| Total noncurrent liabilities | $369.1 | $378.23 | $364.23 | $246.86 |
| Total debt | $430.37 | $438.58 | $391.48 | $273.79 |
| Total liabilities | $676.37 | $688.73 | $583.18 | $445.92 |
| Shareholders' equity | ||||
| Retained earnings | -$2377.44 | -$1942.63 | -$1394.84 | -$929.32 |
| Other shareholder equity | -$3.08 | -$16.36 | -$2.29 | $4.26 |
| Total shareholder equity | $765.33 | $705.74 | $653.3 | $486.24 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $311.11 | $268.31 | $261.4 | $241.76 |
| Cost of revenue | $151.25 | $147.31 | $143.15 | $148.12 |
| Gross Profit | $159.86 | $121 | $118.25 | $93.63 |
| Operating activities | ||||
| Research & development | $82.96 | $77.23 | $78.17 | $82.31 |
| Selling, general & administrative | $161.43 | $154.74 | $152.51 | $149.63 |
| Total operating expenses | $244.39 | $231.98 | $230.68 | $231.93 |
| Operating income | -$84.54 | -$110.98 | -$112.43 | -$138.3 |
| Income from continuing operations | ||||
| EBIT | -$74.69 | -$105.58 | -$107.91 | -$133.72 |
| Income tax expense | $0.19 | $0.2 | -$0.28 | $0.16 |
| Interest expense | $3.15 | $3.25 | $3.18 | $3.06 |
| Net income | ||||
| Net income | -$78.03 | -$109.03 | -$110.8 | -$136.94 |
| Income (for common shares) | -$78.03 | -$109.03 | -$110.8 | -$136.94 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1082.57 | $820.22 | $625.49 | $391 |
| Cost of revenue | $589.83 | $456.26 | $318.42 | $203.62 |
| Gross Profit | $492.74 | $363.97 | $307.07 | $187.38 |
| Operating activities | ||||
| Research & development | $320.68 | $316.42 | $264.21 | $100.03 |
| Selling, general & administrative | $618.31 | $588.59 | $511.03 | $303.63 |
| Total operating expenses | $938.99 | $905.01 | $775.24 | $403.66 |
| Operating income | -$446.25 | -$541.04 | -$468.17 | -$216.28 |
| Income from continuing operations | ||||
| EBIT | -$421.89 | -$537.5 | -$462.79 | -$214.56 |
| Income tax expense | $0.27 | $0.98 | $0.62 | $0.1 |
| Interest expense | $12.64 | $9.32 | $8.3 | $15.08 |
| Net income | ||||
| Net income | -$434.8 | -$547.8 | -$471.72 | -$229.74 |
| Income (for common shares) | -$434.8 | -$547.8 | -$471.72 | -$229.74 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$78.03 | -$109.03 | -$110.8 | -$136.94 |
| Operating activities | ||||
| Depreciation | $10.42 | $10.54 | $8.77 | $8.88 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $48.91 | $57.73 | $44.47 | $40.7 |
| Total cash flows from operations | -$58.13 | -$29.55 | -$78.39 | -$80.89 |
| Investing activities | ||||
| Capital expenditures | -$9.53 | -$9.1 | -$8.97 | -$11.6 |
| Investments | $34.2 | $90.25 | $56 | $27.25 |
| Total cash flows from investing | $24.66 | $81.15 | $47.03 | $15.65 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $6.84 | $236 | $9.31 | $2.3 |
| Net borrowings | ||||
| Total cash flows from financing | $6.84 | $236 | $9.31 | $2.3 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$26.61 | $287.6 | -$22.04 | -$62.94 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$434.8 | -$547.8 | -$471.72 | -$229.74 |
| Operating activities | ||||
| Depreciation | $38.62 | $30.47 | $22.18 | $16.45 |
| Business acquisitions & disposals | -$8.56 | |||
| Stock-based compensation | $191.81 | $152.38 | $115.22 | $50.17 |
| Total cash flows from operations | -$246.96 | -$431.5 | -$335.24 | -$182.51 |
| Investing activities | ||||
| Capital expenditures | -$39.2 | -$47.7 | -$41.03 | -$19.6 |
| Investments | $207.7 | $378.04 | -$155.6 | -$311.86 |
| Total cash flows from investing | $168.5 | $330.34 | -$205.19 | -$331.46 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $254.46 | $452.64 | $576.19 | $301.29 |
| Net borrowings | $30 | $199.56 | ||
| Total cash flows from financing | $254.46 | $482.64 | $576.19 | $500.85 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $176 | $381.48 | $35.76 | -$13.13 |
News
Fundamentals
| Market cap | $10.94B |
|---|---|
| Enterprise value | $10.73B |
| Shares outstanding | 119.58M |
| Revenue | $1.08B |
|---|---|
| EBITDA | -$383.28M |
| EBIT | -$421.89M |
| Net Income | -$434.80M |
| Revenue Q/Q | 43.20% |
| Revenue Y/Y | N/A |
| P/E ratio | -25.16 |
|---|---|
| EV/Sales | 9.91 |
| EV/EBITDA | -28.00 |
| EV/EBIT | -25.43 |
| P/S ratio | 10.11 |
| P/B ratio | 14.24 |
| Book/Share | 6.43 |
| Cash/Share | 5.37 |
| EPS | -$3.64 |
|---|---|
| ROA | -31.88% |
| ROE | -62.19% |
| Debt/Equity | 0.88 |
|---|---|
| Net debt/EBITDA | -0.09 |
| Current ratio | 4.10 |
| Quick ratio | 3.96 |